Practical info

  • No registration needed
  • Follow the symposium live on this page
  • Add your questions to the comments, you will need to fill in a name to add comments
  • Add to your calendar



Opening remarks

Rosalind Hollingsworth, Sanofi Pasteur, United States of America

Burden of influenza diseases in people 65 years old and over

Thomas Weinke, Klinikum Ernst von Bergmann, Germany

High dose influenza vaccine: benefits for older adults

Marc Van Ranst, University of Leuven, Belgium

North America experience: high dose vaccine focus on long term care

Stefan Gravenstein, Case Western Reserve University, United States of America

Q&A and Closing Remarks with Thomas Weinke, Marc Van Ranst, Stefan Gravenstein

Rosalind Hollingsworth, Sanofi Pasteur, United States of America

At the occasion of the 7th ESWI Influenza Conference, virtual edition, 6-9 December 2020 Sanofi Pasteur is organizing a satellite symposium on 8 December 18:00 - 20:00 CET.

10 years of evidence using high dose influenza vaccine in people age 65 and older

Chair: Rosalind Hollingsworth, Sanofi Pasteur